Free Trial

Alliance Pharma (APH) Stock Forecast & Price Target

Alliance Pharma logo

Alliance Pharma - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
1
Buy
0

Consensus Price Target

GBX 6,250
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for APH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alliance Pharma and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APH Analyst Ratings Over Time

TypeCurrent Forecast
10/17/24 to 10/17/25
1 Month Ago
9/17/24 to 9/17/25
3 Months Ago
7/19/24 to 7/19/25
1 Year Ago
10/18/23 to 10/17/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 6,250GBX 6,250GBX 6,250GBX 60
Consensus RatingHoldHoldHoldBuy

APH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

APH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alliance Pharma Stock vs. The Competition

TypeAlliance PharmaMedical Companies
Consensus Rating Score
2.00
2.33
Consensus RatingHoldHold
News Sentiment Rating
Neutral News

See Recent APH News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
1/29/2025Berenberg Bank
2 of 5 stars
 DowngradeHoldGBX 7,000 ➝ GBX 6,250+10,112.42%
1/31/2024Royal Bank Of Canada
3 of 5 stars
 Lower TargetOutperformGBX 65 ➝ GBX 60+59.79%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:57 PM ET.


APH Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Alliance Pharma is GBX 6,250, with a high forecast of GBX 6,250 and a low forecast of GBX 6,250.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" APH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APH, but not buy additional shares or sell existing shares.

According to analysts, Alliance Pharma's stock has a predicted upside of ∞ based on their 12-month stock forecasts.

Analysts like Alliance Pharma less than other "medical" companies. The consensus rating score for Alliance Pharma is 2.00 while the average consensus rating score for "medical" companies is 2.33. Learn more on how APH compares to other companies.


This page (LON:APH) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners